- link Copy URL - [ Share on X ](https://twitter.com/intent/tweet?text=Novo Nordisk Second Best in the World at Providing Access to Medicine https://www.3blmedia.com/markdownify/node/52472?absolute=1&via=3blnews "Share on X") - [ Share on linkedin ](https://www.linkedin.com/shareArticle?mini=true&url=https://www.3blmedia.com/markdownify/node/52472?absolute=1 "Share on Linkedin") - [ Share on facebook ](https://www.facebook.com/sharer/sharer.php?u=https://www.3blmedia.com/markdownify/node/52472?absolute=1 "Share on Facebook") - [ email Share via email ](mailto:?subject=Novo Nordisk Second Best in the World at Providing Access to Medicine&body=ESG News from Novo Nordisk https://www.3blmedia.com/markdownify/node/52472?absolute=1 "Share via email") [Awards & Rankings](/categories/awards-rankings) # Novo Nordisk Second Best in the World at Providing Access to Medicine Nov 17, 2014 10:00 AM ET ![](https://3blcdn.com/styles/carousel_2x/s3/2026-08/Base_of_Pyramid_India_1786917873.jpg "Novo Nordisk's Base of the Pyramid programme provides diabetes education. Bihar, India") Novo Nordisk's Base of the Pyramid programme provides diabetes education. Bihar, India Bagsværd, Denmark, November 17, 2014 /3BL Media/ – Today, it was announced that Novo Nordisk ranks second on the 2014 Access to Medicine Index, climbing four places since the 2012 Index. Novo Nordisk’s ranking is a reflection of the company’s inclusion of access to medicine within its core business, including equitable pricing strategies, local capability building and integrating philanthropy with business activities. In 2013, Novo provided medical treatments for approximately 24.3 million people with diabetes worldwide, showing a 7% increase compared with 2012. “Today, more than 80% of people with diabetes live in low- and middle-income countries where access to medicine and treatment is simply not adequate for the millions in need,” says Lars Rebien Sørensen, chief executive officer at Novo Nordisk. “Last year, we launched our Strategy for Global Access to Diabetes Care strengthening our already existing efforts to break down barriers that inhibit access to care and help us reach 40 million people living with diabetes by 2020.” Since Novo Nordisk launched its first access to care strategy in 2001, diabetes has become a major global health challenge. There are now an estimated 387 million people worldwide with diabetes and the number is expected to rise to over half a billion by 20351. **Working towards sustainable solutions** The 2014 Access to Medicine Index highlighted two of the company’s access to diabetes care initiatives – the[ Base of the Pyramid](http://www.changingdiabetesaccess.com/our-contributions/reaching-the-base-of-the-pyramid.asp) project and the [Changing Diabetes® in Children](http://www.changingdiabetesaccess.com/our-contributions/health-for-the-next-generation.asp) programme. The Base of the Pyramid project takes an integrated approach together with faith-based organisations to improve diagnosis, treatment and diabetes education for the working poor in developing countries. The Changing Diabetes® in Children programme provides medicine free of cost, treatment and patient education for children living with type 1 diabetes in low-income countries. “We have the knowledge, capabilities and commitment to improve the health of people living with diabetes regardless of where they live,” says Lars Rebien Sørensen. “As the world leader in diabetes care, we will continue to work with governments, health organisations and communities to make this a reality across the globe.” **About the Access to Medicine Index** The ranking of the 2014 Access to Medicine Index is based on measurements of 21 pharmaceutical companies’ policies and practices in improving access to medicine across a specific range of countries, diseases and product types. The Access to Medicine Index is published every two years. [Read more about Novo Nordisk’s approach to access to diabetes care](http://www.changingdiabetesaccess.com/) [View the full 2014 Access to Medicine Index](http://www.atmindex.org/) **About Novo Nordisk** Headquartered in Denmark, Novo Nordisk is a global healthcare company with 90 years of innovation and leadership in diabetes care. The company also has leading positions within haemophilia care, growth hormone therapy and hormone replacement therapy. Novo Nordisk strives to conduct its activities in a financially, environmentally and socially responsible way. The strategic commitment to corporate sustainability has brought the company onto centre stage as a leading player in today’s business environment, recognised for its integrated reporting, stakeholder engagement and consistently high sustainability performance. ### Additional Media #### Videos [ ![](https://3blcdn.com/styles/carousel_thumbnail_x2/s3/videos/thumbnails/143078/thumbnail-143078_0006.png?h=7a6e80fd) ](/sites/default/files/videos/comfort-and-the-empty-shop-video.mp4) [![](/sites/default/files/Clients/NN_m_2c_RGB_small.png)](/profiles/novo-nordisk) ### More from Novo Nordisk ###### [How Do We Innovate Diabetes Care in Africa’s Biggest Country?](/news/how-do-we-innovate-diabetes-care-africas-biggest-country) Sep 29, 2016 10:00 AM ET ###### [Diabetes Campaign Launched in Nigeria to Promote Early Diagnosis ](/news/diabetes-campaign-launched-nigeria-promote-early-diagnosis) Sep 20, 2016 10:25 AM ET ###### [Novo Nordisk Improves Score, Remains at the Top of 2016 Dow Jones Sustainability Indices](/news/novo-nordisk-improves-score-remains-top-2016-dow-jones-sustainability-indices) Sep 12, 2016 10:40 AM ET ###### [Helicopter View of A Sustainable City](/news/helicopter-view-sustainable-city) Aug 22, 2016 1:05 PM ET ###### [Partnering with Diabetes At The Centre of the Universe](/news/partnering-diabetes-centre-universe) Aug 10, 2016 10:00 AM ET ###### [\#WeAreNotWaiting](/news/wearenotwaiting) Aug 5, 2016 9:00 AM ET ###### [The Digital Health Connection in Africa](/news/digital-health-connection-africa) Jul 21, 2016 9:00 AM ET ###### [Companies Have Unique Contributions to Bring to the Table](/news/companies-have-unique-contributions-bring-table) Jul 14, 2016 9:00 AM ET